Humoral hypercalcemia in Hodgkin's disease. Clinical and laboratory evaluation
โ Scribed by Joseph O. Jacobson; F. Richard Bringhurst; Nancy L. Harris; Sigmund A. Weitzman; Alan C. Aisenberg
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 750 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The etiology of hypercalcemia was investi-(PTHrP 1-86) detected by immunoradiometric gated in a patient with primary isolated non-assay was increased (15 pmol/l compared with Hodgkin's lymphoma of the heart. There was no ฯฝ 0.3 pmol/l in a control). We demonstrated evidence of bone involvement, and p
I n 163 consecutively irradiated patients with Hodgkin's disease, Stage 1-111, herpes zoster subsequently occurred in 31 (19%). The incidence of zoster was increased in patients with mixed cellularity histology, Stage 111 disease, and in those patients with early stages treated with extensive irradi
Seventy-two patients with Hodgkin's disease, reticulum cell sarcoma, lymphosarcoma, and various other malignant neoplasms were treated with the methylhydrazine derivative procarbazine hydrochloride (Matulane,@ NSC-77213). Response to therapy could be evaluated in 50 patients. Favorable responses occ